What End Users and Stakeholders Want From Automated Insulin Delivery Systems.

Diana NaranjoSakinah C SuttiratanaEsti IturraldeKatharine D BarnardJill Weissberg-BenchellLori M B Laffel Korey K Hood

Published in: Diabetes care (2017)

Incorporating stakeholder perspectives on use of automated insulin delivery systems will improve the adoption of devices, quality of life, and likelihood of optimal health. Efforts to build trust in systems, optimize user-system interactions, and provide clear guidance about device capabilities and limitations may help potential users achieve optimal glycemic outcomes.

Keyphrases

type diabetes
glycemic control
deep learning
machine learning
high throughput
health information
healthcare
public health
human health
mental health
electronic health record
quality improvement
insulin resistance
metabolic syndrome
social media